These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Epidemiology and risk of hypertension in the elderly. Reed G; Anderson RJ Clin Ther; 1982; 5 Spec No():1-7. PubMed ID: 7116363 [No Abstract] [Full Text] [Related]
23. [Prospective cardiovascular studies in a selected population. Results of the initial study]. Kornitzer M; Demeester M; Delcourt R; Goossens A; Bernard R Acta Cardiol; 1971; 26(3):285-343. PubMed ID: 5315280 [No Abstract] [Full Text] [Related]
24. [Cardiovascular epidemiology in Italy in the 70's]. Menotti A G Ital Cardiol; 1981; 11 Suppl 1():42-53. PubMed ID: 7035276 [No Abstract] [Full Text] [Related]
26. Cardiovascular benefits of estrogen replacement therapy. Ross RK; Paganini-Hill A; Mack TM; Henderson BE Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1301-6. PubMed ID: 2655453 [TBL] [Abstract][Full Text] [Related]
27. [Methods in epidemiological studies of cardiovascular diseases based on tracing of so-called risk factors. I]. Santrůcek M Zdrav Prac; 1977 May; 27(5):302-4. PubMed ID: 242498 [No Abstract] [Full Text] [Related]
28. Editorial: Precursors of Cardiovascular Disease in Adolescent Type 1 Diabetes. Hoffman RP Curr Diabetes Rev; 2017; 13(6):519. PubMed ID: 29039272 [No Abstract] [Full Text] [Related]
29. Cardiovascular disease in Missouri: mortality, hospital discharges and risk factors. Brownson RC; Van Tuinen M; Smith CA Mo Med; 1990 Apr; 87(4):225-7. PubMed ID: 2325597 [TBL] [Abstract][Full Text] [Related]
30. [Cardiovascular diseases in populations]. Nava Rhode JR; García Barrios H; Puigbó JJ; Valero JA; Valecillos RI; Pieters G Rev Venez Sanid Asist Soc; 1970 Mar; 35(1):103-6. PubMed ID: 5515680 [No Abstract] [Full Text] [Related]
34. Gender, age, social level and cardiovascular risk factors: considerations on the Brazilian reality. Scherr C; Ribeiro JP Arq Bras Cardiol; 2009 Sep; 93(3):e54-6. PubMed ID: 19851643 [No Abstract] [Full Text] [Related]
35. Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power. Ueland PM; Clarke R Clin Chem; 2007 May; 53(5):807-9. PubMed ID: 17468406 [No Abstract] [Full Text] [Related]
37. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Cacoub PP; Zeymer U; Limbourg T; Baumgartner I; Poldermans D; Röther J; Bhatt DL; Steg PG; Heart; 2011 Apr; 97(8):660-7. PubMed ID: 21357372 [TBL] [Abstract][Full Text] [Related]
38. The French paradox and other ecological fallacies. Evans A Int J Epidemiol; 2011 Dec; 40(6):1486-9. PubMed ID: 22268235 [No Abstract] [Full Text] [Related]
39. [Evaluation of epidemiologic studies on the occurrence of cardiovascular diseases and essential risk factors using automatic data processing]. Knappe J; Rittmeister H; Dück KD Z Arztl Fortbild (Jena); 1972 Jan; 66(2):100-1. PubMed ID: 5061649 [No Abstract] [Full Text] [Related]
40. [Mailed questionnaires in epidemiologic surveys of cardiovascular diseases]. Santrůcek M Cesk Zdrav; 1970 Feb; 18(2):81-4. PubMed ID: 5417428 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]